Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy

Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient

(2013) L. D. C. Hoefnagel et al.   ANNALS OF ONCOLOGY

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

(2013) Nancy U. Lin et al.   BREAST

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

(2012) Yan Lin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Stem cell-related markers in primary breast cancers and associated metastatic lesions

(2012) Gulnur Guler et al.   MODERN PATHOLOGY

In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas

(2012) Giuseppe Perrone et al.   PLoS One

Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review

(2012) Tadashi Kobayashi et al.   Breast Cancer

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy

(2010) Ho-Young Yhim et al.   CANCER

Clinical features of surgical resection for pulmonary metastasis from breast cancer

(2008) F. Chen et al.   EJSO

Pulmonary metastases of breast cancer. When is resection indicated?

(2008) Stefan Welter et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas

(2008) Eleni Mylona et al.   HUMAN PATHOLOGY

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute